DONALDSON Co INC acquired Univercells Technologies (UTEC) for EUR 134.2 million / $146.9 million (net of cash acquired), a transaction completed in June 2023, structured as all cash.
Univercells Technologies (UTEC) operates in Life Sciences, is based in Headquartered in Nivelles, Belgium. UTEC is a global producer of innovative biomanufacturing solutions for cell and gene therapy research, development and commercial manufacturing. Its offering includes the scale-X single-use structured fixed-bed bioreactor for intensified production of viruses used in cell and gene therapy and viral vaccines, and the automated NevoLine Upstream platform that integrates industry-standard filtration for up- and mid-stream processing in a single unit.
Expands Donaldson's bioprocessing equipment and consumables capabilities supporting the development and production of biologic drugs and genetic medicines.
Life Sciences segment
On June 29, 2023, the Company acquired UTEC, headquartered in Nivelles, Belgium, for cash consideration of EUR 134.2 million, or $146.9 million, net of cash acquired. UTEC is a global producer of innovative biomanufacturing solutions for cell and gene therapy research, development and commercial manufacturing.Donaldson FY2023 10-K, Note 2 Acquisitions
Advisory firms were not disclosed for this transaction.